Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Lung Cancer

Free Subscription 27.05.2019 1 AJR Am J Roentgenol 2 Ann Surg Oncol 1 Ann Thorac Surg 2 Anticancer Res 1 Arch Bronconeumol 3 BMC Cancer 1 Br J Cancer 2 Clin Cancer Res 4 Clin Nucl Med 1 Hum Pathol 1 Int J Cancer 2 Int J Oncol 1 J Natl Cancer Inst 1 J Thorac Cardiovasc Surg 4 J Thorac Oncol 1 Nat Med 1 Nat Rev Cancer 3 Oncogene 1 Oncol Rep 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. KIM HK, Han J, Franks TJ, Lee KS, et al
   Colloid Adenocarcinoma of the Lung: CT and PET/CT Findings in Seven Patients.
   AJR Am J Roentgenol. 2018 May 24:W1-W8. doi: 10.2214/AJR.17.19273.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg Oncol

2. LIN MW, Huang YL, Yang CY, Kuo SW, et al
   The Differences in Clinicopathologic and Prognostic Characteristics Between Surgically Resected Peripheral and Central Lung Squamous Cell Carcinoma.
   Ann Surg Oncol. 2019;26:217-229.
   PubMed     Text format     Abstract available
   
   
3. KAWAGUCHI Y, Hanaoka J, Ohshio Y, Okamoto K, et al
   Patient Survival after Surgical Management in Intrathoracic Pseudomyxoma peritonei.
   Ann Surg Oncol. 2019;26:238-243.
   PubMed     Text format     Abstract available
   
   

   
   Ann Thorac Surg

4. SHIMAMATSU S, Takenoyama M, Shimokawa M, Takada K, et al
   The influence of clinical T factor on predicting pathological N factor in resected lung cancer.
   Ann Thorac Surg. 2019 May 16. pii: S0003-4975(19)30703.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

5. KINOSHITA F, Toyokawa G, Matsubara T, Kozuma Y, et al
   Prognosis of Early-stage Part-solid and Pure-solid Lung Adenocarcinomas.
   Anticancer Res. 2019;39:2665-2670.
   PubMed     Text format     Abstract available
   
   
6. LINDBLOM EK, Dasu A, Toma-Dasu I
   Hypoxia Induced by Vascular Damage at High Doses Could Compromise the Outcome of Radiotherapy.
   Anticancer Res. 2019;39:2337-2340.
   PubMed     Text format     Abstract available
   
   

   
   Arch Bronconeumol

7. GOROSPE L, Ayala-Carbonero AM, Ajuria-Illarramendi O, Cabanero-Sanchez A, et al
   Lung Cancer Invading a Coronary Artery Bypass Graft and Presenting as Refractory Atrial Flutter.
   Arch Bronconeumol. 2019 May 18. pii: S0300-2896(19)30216.
   PubMed     Text format    
   
   

   
   BMC Cancer

8. WANG W, Men Y, Wang J, Zhou Z, et al
   Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy.
   BMC Cancer. 2019;19:478.
   PubMed     Text format     Abstract available
   
   
9. YU L, Tao G, Zhu L, Wang G, et al
   Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis.
   BMC Cancer. 2019;19:464.
   PubMed     Text format     Abstract available
   
   
10. VAN NEST SJ, Nicholson LM, Pavey N, Hindi MN, et al
    Raman spectroscopy detects metabolic signatures of radiation response and hypoxic fluctuations in non-small cell lung cancer.
    BMC Cancer. 2019;19:474.
    PubMed     Text format     Abstract available
    
    

    
    Br J Cancer

11. SELLERS K, Allen TD, Bousamra M 2nd, Tan J, et al
    Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes.
    Br J Cancer. 2019 May 22. pii: 10.1038/s41416-019-0464.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

12. HU-LIESKOVAN S, Lisberg A, Zaretsky JM, Grogan TR, et al
    Tumor characteristics associated with benefit from pembrolizumab in advanced non-small cell lung cancer.
    Clin Cancer Res. 2019 May 21. pii: 1078-0432.CCR-18-4275.
    PubMed     Text format     Abstract available
    
    
13. SU Z, Wang Z, Ni X, Duan J, et al
    Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells.
    Clin Cancer Res. 2019 May 21. pii: 1078-0432.CCR-18-3571.
    PubMed     Text format     Abstract available
    
    

    
    Clin Nucl Med

14. LUBIN DJ, Holden SB, Rettig MB, Reiter RE, et al
    Prostate Cancer Pulmonary Metastasis Presenting as a Ground-Glass Pulmonary Nodule on 68Ga-PSMA-11 PET/CT.
    Clin Nucl Med. 2019 Feb 15. doi: 10.1097/RLU.0000000000002499.
    PubMed     Text format     Abstract available
    
    
15. GARCIA-TALAVERA P, Colinas D, Tamayo P, Fra J, et al
    18F-FDG PET/CT of Lung Adenocarcinoma With Ovarian Metastases.
    Clin Nucl Med. 2019 Feb 15. doi: 10.1097/RLU.0000000000002490.
    PubMed     Text format     Abstract available
    
    
16. WANG W, Kan Y, Yang X, Liu J, et al
    Concurrent Pancreatic Metastasis From Lung Adenocarcinoma and Primary Cholangiocarcinoma on FDG PET/CT Imaging.
    Clin Nucl Med. 2019 Feb 8. doi: 10.1097/RLU.0000000000002496.
    PubMed     Text format     Abstract available
    
    
17. CHUANG TL, Hsu TW, Chou SC, Wang YF, et al
    Car Accident With Airbag Deployment Trauma Showed Special Pattern in Bone Scan.
    Clin Nucl Med. 2019;44:429-430.
    PubMed     Text format     Abstract available
    
    

    
    Hum Pathol

18. MUNARI E, Zamboni G, Lunardi G, Marconi M, et al
    PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays.
    Hum Pathol. 2019 May 20. pii: S0046-8177(19)30088.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

19. WANG L, Zhao H, Xu Y, Li J, et al
    Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.
    Int J Cancer. 2019;144:1723-1734.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

20. LI Y, Yang Y, Gan T, Zhou J, et al
    Extracellular RNAs from lung cancer cells activate epithelial cells and induce neutrophil extracellular traps.
    Int J Oncol. 2019 May 21. doi: 10.3892/ijo.2019.4808.
    PubMed     Text format     Abstract available
    
    
21. MIN TR, Park HJ, Ha KT, Chi GY, et al
    Suppression of EGFR/STAT3 activity by lupeol contributes to the induction of the apoptosis of human nonsmall cell lung cancer cells.
    Int J Oncol. 2019 May 7. doi: 10.3892/ijo.2019.4799.
    PubMed     Text format     Abstract available
    
    

    
    J Natl Cancer Inst

22. CONFORTI F, Pala L, Bagnardi V, Viale G, et al
    Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis.
    J Natl Cancer Inst. 2019 May 20. pii: 5491832. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Thorac Cardiovasc Surg

23. LANUTI M
    Commentary: Cautious optimism for induction immunotherapy in resectable lung cancer.
    J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30926.
    PubMed     Text format    
    
    

    
    J Thorac Oncol

24. SPIGEL DR, McCleod M, Jotte RM, Einhorn L, et al
    Safety, Efficacy, and Patient-reported Health-related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer, Including Patients Aged >/=70 Years or with Poor Performance Status (CheckMate 153).
    J Thorac Oncol. 2019 May 20. pii: S1556-0864(19)30376.
    PubMed     Text format     Abstract available
    
    
25. LEE Y, Kim TM, Kim DW, Kim S, et al
    Pre-clinical Modeling of Osimertinib for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.
    J Thorac Oncol. 2019 May 17. pii: S1556-0864(19)30369.
    PubMed     Text format     Abstract available
    
    
26. FLIPPOT R, Biondani P, Auclin E, Xiao D, et al
    Activity of epidermal growth factor tyrosine kinase inhibitors in non-small cell lung carcinoma with refractory leptomeningeal metastases.
    J Thorac Oncol. 2019 May 17. pii: S1556-0864(19)30370.
    PubMed     Text format     Abstract available
    
    
27. MURPHY SJ, Harris FR, Kosari F, Terra S, et al
    Using genomics to differentiate multiple primaries from metastatic lung cancer.
    J Thorac Oncol. 2019 May 16. pii: S1556-0864(19)30374.
    PubMed     Text format     Abstract available
    
    

    
    Nat Med

28. ARDILA D, Kiraly AP, Bharadwaj S, Choi B, et al
    End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography.
    Nat Med. 2019 May 20. pii: 10.1038/s41591-019-0447.
    PubMed     Text format     Abstract available
    
    

    
    Nat Rev Cancer

29. ALTORKI NK, Markowitz GJ, Gao D, Port JL, et al
    The lung microenvironment: an important regulator of tumour growth and metastasis.
    Nat Rev Cancer. 2019;19:9-31.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

30. ZHU J, Huang G, Hua X, Li Y, et al
    CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells.
    Oncogene. 2019 Jan 11. pii: 10.1038/s41388-018-0664.
    PubMed     Text format     Abstract available
    
    
31. HUANG JJ, Corona AL, Dunn BP, Cai EM, et al
    Increased type III TGF-beta receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition.
    Oncogene. 2019;38:3402-3414.
    PubMed     Text format     Abstract available
    
    
32. SEPULT C, Bellefroid M, Rocks N, Donati K, et al
    ADAM10 mediates malignant pleural mesothelioma invasiveness.
    Oncogene. 2019;38:3521-3534.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

33. XIA Y, Hu C, Lian L, Hui K, et al
    miR497 suppresses malignant phenotype in nonsmall cell lung cancer via targeting KDR.
    Oncol Rep. 2019 May 16. doi: 10.3892/or.2019.7163.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

34. SUZUKI A, Puri S, Leland P, Puri A, et al
    Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer.
    PLoS One. 2019;14:e0217131.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

35. CROW M, Lim N, Ballouz S, Pavlidis P, et al
    Predictability of human differential gene expression.
    Proc Natl Acad Sci U S A. 2019;116:6491-6500.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: